MyoKardia (MYOK) Priced

Clinical-stage biotech developing therapies for heritable cardiomyopathies.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $11.95 -0.25 (-2.0%)
First Day Return 5.3%
Return from IPO 22.0%
 
MyoKardia IPO News more
  • .
IPO Data
IPO File Date 09/28/2015
Offer Price $10.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.4
Deal Size ($mm) 54
 
IPO Data
IPO Date 10/28/2015
Offer Price $10.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.4
Deal Size ($mm) $54
 
Underwriters
more
Business Overview
Clinical-stage biotech developing therapies for heritable cardiomyopathies.
Clinical-stage biotech developing therapies for heritable cardiomyopathies.
more
Company Data
Headquarters South San Francisco, CA
Founded 2012
Employees 54
Website www.myokardia.com
 

Performance vs. IPO Index (IPOUSA)